Research and Markets: Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Review, Development & Analysis Report 2015
November 26 2015 - 5:15AM
Business Wire
Research and Markets
(http://www.researchandmarkets.com/research/hrcq3w/rheumatoid) has
announced the addition of the "Rheumatoid - Inflammatory Diseases
Markers Tests - Pipeline Review, 2015" report to their
offering.
This Medical Devices sector report, Rheumatoid - Inflammatory
Diseases Markers Tests - Pipeline Review, 2015" provides an
overview of Rheumatoid - Inflammatory Diseases Markers Tests
currently in pipeline stage.
The report provides comprehensive information on the pipeline
products with comparative analysis of the products at various
stages of development. The report reviews major players involved in
the pipeline product development. It also provides information
about clinical trials in progress, which includes trial phase,
trial status, trial start and end dates, and, the number of trials
for the key Rheumatoid - Inflammatory Diseases Markers Tests
pipeline products.
Key Topics Covered:
- Extensive coverage of the Rheumatoid - Inflammatory Diseases
Markers Tests under development
- The report reviews details of major pipeline products which
includes, product description, licensing and collaboration details
and other developmental activities
- The report reviews the major players involved in the
development of Rheumatoid - Inflammatory Diseases Markers Tests and
list all their pipeline projects
- The coverage of pipeline products based on various stages of
development ranging from Early Development to Approved / Issued
stage
- The report provides key clinical trial data of ongoing trials
specific to pipeline products
- Recent developments in the segment / industry
Benefits of this Report:
- Formulate significant competitor information, analysis, and
insights to improve R&D strategies
- Identify emerging players with potentially strong product
portfolio and create effective counter-strategies to gain
competitive advantage
- Identify and understand important and diverse types of
Rheumatoid - Inflammatory Diseases Markers Tests under
development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major
players with the most promising pipeline
- In-depth analysis of the product's current stage of
development, territory and estimated launch date
Companies Mentioned Include:
- Abcodia Ltd.
- Albert-Ludwigs-Universitat Freiburg
- Analyticon Biotechnologies AG
- AnaMar AB
- Fundacio Clinic per a la Recerca Biomedica
- Genalyte, Inc.
- Proplex Technologies, Llc
- Protagen AG
- Selventa
- Siemens Healthcare Diagnostics Inc.
- Thermo Fisher Scientific Inc.
- Toscana Biomarkers Srl
- University of Aberdeen
- University of Manchester
Key Topics Covered:
1.1 List of Tables
1.2 List of Figures
2 Introduction
3 Products under Development
4 Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline
Products under Development by Companies
5 Rheumatoid - Inflammatory Diseases Markers Tests Companies and
Product Overview
6 Rheumatoid - Inflammatory Diseases Markers Tests- Recent
Developments
7 Appendix
For more information visit
http://www.researchandmarkets.com/research/hrcq3w/rheumatoid
View source
version on businesswire.com: http://www.businesswire.com/news/home/20151126005098/en/
Research and MarketsLaura Wood, Senior
Managerpress@researchandmarkets.comFor E.S.T. Office Hours Call
1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT
Office Hours Call +353-1-416-8900U.S. Fax: 646-607-1907Fax (outside
U.S.): +353-1-481-1716Sector: In Vitro Diagnostics, Biomarkers